Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • MORSCHHAUSER F
    • BURGER H-U
    • BRENNAN B
    • MENDILA M
    • MARLTON P
    • VITOLO U
    • LINDEN O
    • PROF John Seymour
    • CRUMP M
    • COIFFIER B
    • FOA R
    • WASSNER E

Published in

  • Annals of Oncology

Time

Date/time value

  • 2010

Identity

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdq027

Additional Document Info

Parent Title

  • ANNALS OF ONCOLOGY

Volume

  • 21

Issue

  • 9

Publisher

  • Oxford University Press